Figure 1From: Update on the use of aromatase inhibitors in early-stage breast cancerGuidelines on the management of postmenopausal women treated with aromatase inhibitors. AST, aspartate aminotransferase; BMD, bone mineral density; BMI, body mass index; DXA, dual-energy x-ray absorptiometry; ESR, erythrocyte sedimentation rate; FBC, full blood count; GT, glutamine transpeptidase. Adapted with permission from [81].Back to article page